Status:
UNKNOWN
Improving Access to Breast Cancer Screening and Treatment in Nigeria: The Triple Mobile Assessment and Patient Navigation Model
Lead Sponsor:
Obafemi Awolowo University
Collaborating Sponsors:
Pfizer
Conditions:
Breast Cancer
Eligibility:
FEMALE
30-70 years
Phase:
NA
Brief Summary
The goal of this study is to establish a novel community-based breast cancer program to address delayed presentation and lack of access to diagnostic and treatment facilities in South-West Nigeria. It...
Detailed Description
This study aims to provide screening to asymptomatic women 40-70 years and to provide diagnostic evaluation to women 30-70 years presenting with breast symptoms in a community in South-West Nigeria. ...
Eligibility Criteria
Inclusion
- Asymptomatic women 40 - 70 years
- Symptomatic women (with breast-related symptoms) 30 - 70 years
Exclusion
- Male subjects
- Women living outside the study locations (Ife East and Ife North districts)
Key Trial Info
Start Date :
December 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2023
Estimated Enrollment :
4100 Patients enrolled
Trial Details
Trial ID
NCT05321823
Start Date
December 8 2021
End Date
October 31 2023
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obafemi Awolowo University Teaching Hospitals Complex
Ile-Ife, Osun State, Nigeria, 220213